vs
安霸（AMBA）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
安霸的季度营收约是RIGEL PHARMACEUTICALS INC的1.6倍（$108.5M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -13.9%，领先398.0%），安霸同比增速更快（31.2% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 45.0%）
安霸是美国无晶圆厂半导体设计企业，专注于低功耗高清、超高清视频压缩、图像处理及计算机视觉处理器研发。其芯片产品广泛应用于视频安防、高级驾驶辅助系统、电子后视镜、行车记录仪、驾驶舱内监测、自动驾驶、机器人等多元人机视觉场景。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
AMBA vs RIGL — 直观对比
营收规模更大
AMBA
是对方的1.6倍
$69.8M
营收增速更快
AMBA
高出10.0%
21.2%
净利率更高
RIGL
高出398.0%
-13.9%
两年增速更快
RIGL
近两年复合增速
45.0%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $108.5M | $69.8M |
| 净利润 | $-15.1M | $268.1M |
| 毛利率 | 59.6% | 91.5% |
| 营业利润率 | -15.0% | 33.2% |
| 净利率 | -13.9% | 384.0% |
| 营收同比 | 31.2% | 21.2% |
| 净利润同比 | 37.2% | 1769.2% |
| 每股收益（稀释后） | $-0.35 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMBARIGL
| Q4 25 | $108.5M | $69.8M | ||
| Q3 25 | $95.5M | $69.5M | ||
| Q2 25 | $85.9M | $101.7M | ||
| Q1 25 | $84.0M | $53.3M | ||
| Q4 24 | $82.7M | $57.6M | ||
| Q3 24 | $63.7M | $55.3M | ||
| Q2 24 | $54.5M | $36.8M | ||
| Q1 24 | $51.6M | $29.5M |
净利润AMBARIGL
| Q4 25 | $-15.1M | $268.1M | ||
| Q3 25 | $-20.0M | $27.9M | ||
| Q2 25 | $-24.3M | $59.6M | ||
| Q1 25 | $-20.2M | $11.4M | ||
| Q4 24 | $-24.1M | $14.3M | ||
| Q3 24 | $-34.9M | $12.4M | ||
| Q2 24 | $-37.9M | $-1.0M | ||
| Q1 24 | $-60.6M | $-8.2M |
毛利率AMBARIGL
| Q4 25 | 59.6% | 91.5% | ||
| Q3 25 | 58.9% | 93.2% | ||
| Q2 25 | 60.0% | 95.6% | ||
| Q1 25 | 60.0% | 91.7% | ||
| Q4 24 | 60.6% | 89.9% | ||
| Q3 24 | 60.8% | 85.5% | ||
| Q2 24 | 60.9% | 92.4% | ||
| Q1 24 | 59.8% | 93.1% |
营业利润率AMBARIGL
| Q4 25 | -15.0% | 33.2% | ||
| Q3 25 | -23.0% | 40.9% | ||
| Q2 25 | -30.1% | 60.1% | ||
| Q1 25 | -30.2% | 23.9% | ||
| Q4 24 | -30.9% | 28.9% | ||
| Q3 24 | -56.9% | 25.4% | ||
| Q2 24 | -72.4% | 1.2% | ||
| Q1 24 | -80.8% | -23.6% |
净利率AMBARIGL
| Q4 25 | -13.9% | 384.0% | ||
| Q3 25 | -20.9% | 40.2% | ||
| Q2 25 | -28.3% | 58.6% | ||
| Q1 25 | -24.1% | 21.5% | ||
| Q4 24 | -29.1% | 24.9% | ||
| Q3 24 | -54.8% | 22.5% | ||
| Q2 24 | -69.6% | -2.8% | ||
| Q1 24 | -117.4% | -27.9% |
每股收益（稀释后）AMBARIGL
| Q4 25 | $-0.35 | $14.11 | ||
| Q3 25 | $-0.47 | $1.46 | ||
| Q2 25 | $-0.58 | $3.28 | ||
| Q1 25 | $-0.48 | $0.63 | ||
| Q4 24 | $-0.58 | $0.82 | ||
| Q3 24 | $-0.85 | $0.70 | ||
| Q2 24 | $-0.93 | $-0.06 | ||
| Q1 24 | $-1.51 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $174.1M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $590.1M | $391.5M |
| 总资产 | $751.9M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资AMBARIGL
| Q4 25 | $174.1M | $155.0M | ||
| Q3 25 | $142.7M | $137.1M | ||
| Q2 25 | $141.3M | $108.4M | ||
| Q1 25 | $144.6M | $77.1M | ||
| Q4 24 | $127.1M | $77.3M | ||
| Q3 24 | $153.9M | $61.1M | ||
| Q2 24 | $131.8M | $49.1M | ||
| Q1 24 | $144.9M | $49.5M |
总债务AMBARIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益AMBARIGL
| Q4 25 | $590.1M | $391.5M | ||
| Q3 25 | $576.5M | $117.6M | ||
| Q2 25 | $572.7M | $81.9M | ||
| Q1 25 | $561.4M | $18.6M | ||
| Q4 24 | $554.3M | $3.3M | ||
| Q3 24 | $547.6M | $-14.6M | ||
| Q2 24 | $555.4M | $-29.9M | ||
| Q1 24 | $559.9M | $-31.7M |
总资产AMBARIGL
| Q4 25 | $751.9M | $513.6M | ||
| Q3 25 | $706.4M | $242.5M | ||
| Q2 25 | $701.9M | $206.7M | ||
| Q1 25 | $689.0M | $176.0M | ||
| Q4 24 | $670.8M | $164.0M | ||
| Q3 24 | $650.3M | $139.4M | ||
| Q2 24 | $638.7M | $128.4M | ||
| Q1 24 | $657.7M | $126.5M |
负债/权益比AMBARIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $34.3M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $31.4M | — |
| 自由现金流率自由现金流/营收 | 29.0% | — |
| 资本支出强度资本支出/营收 | 2.7% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $64.3M | — |
8季度趋势，按日历期对齐
经营现金流AMBARIGL
| Q4 25 | $34.3M | $22.0M | ||
| Q3 25 | $5.5M | $24.0M | ||
| Q2 25 | $14.8M | $30.5M | ||
| Q1 25 | $25.4M | $-893.0K | ||
| Q4 24 | $6.6M | $14.5M | ||
| Q3 24 | $16.7M | $21.7M | ||
| Q2 24 | $-15.0M | $302.0K | ||
| Q1 24 | $-4.0M | $-5.0M |
自由现金流AMBARIGL
| Q4 25 | $31.4M | — | ||
| Q3 25 | $1.4M | — | ||
| Q2 25 | $10.2M | — | ||
| Q1 25 | $21.2M | — | ||
| Q4 24 | $4.1M | — | ||
| Q3 24 | $14.2M | — | ||
| Q2 24 | $-16.1M | — | ||
| Q1 24 | $-6.0M | — |
自由现金流率AMBARIGL
| Q4 25 | 29.0% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 11.9% | — | ||
| Q1 25 | 25.3% | — | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 22.2% | — | ||
| Q2 24 | -29.5% | — | ||
| Q1 24 | -11.6% | — |
资本支出强度AMBARIGL
| Q4 25 | 2.7% | — | ||
| Q3 25 | 4.3% | — | ||
| Q2 25 | 5.3% | — | ||
| Q1 25 | 5.0% | — | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | 3.7% | — |
现金转化率AMBARIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMBA
| TW | $76.0M | 70% |
| Asia Pacific Other Than Taiwan | $20.2M | 19% |
| North America Other Than United States | $7.4M | 7% |
| Other | $5.0M | 5% |
RIGL
暂无分部数据
